[1]
“COMPARISON OF ANTI-MICROBIAL SUSCEPTIBILITY OF AZITHROMYCIN AND LEVOFLOXACIN AGAINST Pseudomonas aeruginosa AND Salmonella typhi”, RMSR, vol. 3, no. 9, pp. 119–126, Sep. 2025, Accessed: Sep. 01, 2026. [Online]. Available: https://medicalsciencereview.com/index.php/Journal/article/view/2054